Clindamycin Phosphate and Tretinoin
These highlights do not include all the information needed to use CLINDAMYCIN PHOSPHATE AND TRETINOIN GEL safely and effectively. See full prescribing information for CLINDAMYCIN PHOSPHATE AND TRETINOIN GEL. CLINDAMYCIN PHOSPAHTE AND TRETINOIN gel, for topical use only Initial U.S. Approval: 2006
Approved
Approval ID
c3ad6c2d-d106-464d-8e27-67ae94793e88
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 18, 2023
Manufacturers
FDA
Solaris Pharma Corporation
DUNS: 079904672
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
clindamycin phosphate and tretinoin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code73473-306
Application NumberANDA212845
Product Classification
M
Marketing Category
C73584
G
Generic Name
clindamycin phosphate and tretinoin
Product Specifications
Route of AdministrationTOPICAL
Effective DateOctober 18, 2023
FDA Product Classification
INGREDIENTS (2)
CLINDAMYCIN PHOSPHATEActive
Quantity: 10 mg in 1 g
Code: EH6D7113I8
Classification: ACTIM
TRETINOINActive
Quantity: 0.25 mg in 1 g
Code: 5688UTC01R
Classification: ACTIB